FUBP1 and colorectal carcinoma: In summary, our research demonstrates that elevated FUBP1 in CRC directly upregulates DVL1 and enhances the Wnt/β‐catenin pathway, thereby increasing stemness, promoting metastasis, and conferring a poor prognosis.